Clinical Trials

Phase 2 Not yet recruiting

1,295 enrolled

Breast

Anatomic Stage II Breast Cancer AJCC v8

NCT07625527 2026-06-04

Is Prolonged Systemic Immunotherapy Necessary After Achieving Tumor-free Status in Patients With Extensive Transurethrally Unresectable Very-high-risk NMIBC?

Non-Muscle Invasive Bladder Neoplasms, Neoplasms

NCT04519879 2026-06-03

White Button Mushroom Sup for the Reduction of PSA in Pts With Biochemically Rec or Therapy Naive Fav Risk Prostate CA

Phase 2 Suspended

133 enrolled

Prostatic Neoplasms

NCT05976763 2026-06-02

Testing Continuous Versus Intermittent Treatment With the Study Drug Zanubrutinib for Older Patients With Previously Untreated Mantle Cell Lymphoma

421 enrolled

Lymphoid

Lymphoma, Mantle-Cell

NCT06974370 2026-05-26

ACTION-Brain

45 enrolled

CNS

Brain Neoplasms

NCT06998342 2026-05-26

MOHSAHRTSS

24 enrolled

Head and Neck Neoplasms

NCT07023432 2026-05-22

Belzutifan's Role in Active Surveillance Versus Treatment for Indolentmetastatic Clear Cell Renal Ccell Carcinoma (BRAVE-RCC)

78 enrolled

Phase EARLY_PHASE1 Recruiting

Carcinoma, Renal Cell

NCT03594630 2026-05-20

Active Surveillance and Chemotherapy Before Surgery in Treating Participants With Stage II-III Rectal Cancer

Rectal Neoplasms

NCT07513389 2026-05-20

Omission of Postoperative Radiation in HPV-Associated Oropharyngeal Cancer Using ctHPVDNA Surveillance (OPERATION)

36 enrolled

Phase 3 Not yet recruiting

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell

NCT07591493 2026-05-15

ADJUPANET

300 enrolled

EndocrineGastrointestinalNET

Pancreatic Neuroendocrine Tumors (pNET)

NCT06733350 2026-05-14

Testosterone Replacement Therapy for the Treatment of Low Testosterone in Hypogonadal Men With Localized Prostate Cancer on Active Surveillance

Phase 4 Recruiting

600 enrolled

Phase NA Not yet recruiting

Prostatic Neoplasms

NCT07576842 2026-05-08

Testing the Feasibility of Different HPV Screening and Care Strategies for Women Living With HIV

750 enrolled

Phase 2/3 Active not recruiting

Acquired Immunodeficiency Syndrome, Uterine Cervical Dysplasia, Uterine Cervical Neoplasms

NCT02135042 2026-05-07

Individualized Treatment Treating Patients With Stage II-IVB Nasopharyngeal Cancer Based on EBV DNA

685 enrolled

Nasopharyngeal Carcinoma, Epstein-Barr Virus Infections

NCT02609685 2026-05-07

PMCAS

216 enrolled

Papillary Thyroid Microcarcinoma, Thyroid Neoplasms

NCT03180268 2026-05-07

Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely Removed by Surgery

Phase 3 Active not recruiting

163 enrolled

CNS

Meningioma

NCT06745024 2026-05-04

Comparing Radiation Therapy to Usual Treatment for Patients With High-Risk Bone Metastases That Are Not Causing Pain, PREEMPT Trial

280 enrolled

Tumor-Agnostic

Neoplasm Metastasis

NCT03803553 2026-05-01

Identification and Treatment Of Micrometastatic Disease in Stage III Colon Cancer

400 enrolled

Colonic Neoplasms

NCT06378866 2026-04-20

DIVINE

532 enrolled

Prostatic Neoplasms

NCT07405476 2026-04-17

Zanidatamab Before Surgery for the Treatment of HER2 Positive Colon and Rectal Cancer in Patients Planned for Curative Intent Treatment

38 enrolled

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT06539468 2026-04-14

Active Surveillance for the Treatment of Low-Risk Basal Cell Carcinoma in Elderly Patients

200 enrolled

Dermatologic

Carcinoma, Basal Cell

NCT05873608 2026-04-06

Communication Issues in Patient and Provider Discussions of Immunotherapy

Phase 4 Not yet recruiting

125 enrolled

Other solid neoplasm

Hematopoietic and Lymphoid System Neoplasm

NCT07281547 2026-02-18

Low Dose Aspirin to Lower Inflammation and Prevent Endometrial Cancer in Postmenopausal Women With Non-atrophic Endometrial Changes and Pain

25 enrolled

Endometrial Neoplasms

NCT03516617 2026-02-09

Acalabrutinib With or Without Obinutuzumab in Treating Patients With Early-Stage Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell

NCT05333874 2026-02-09

CIPHER Study: Pilot Study to Study the Role of ctDNA in Triple Negative and HER2 Positive Early Stage

Phase EARLY_PHASE1 Active not recruiting

34 enrolled

Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT07370675 2026-01-27

Active Surveillance for Bethesda IV Thyroid Nodules

165 enrolled

Phase 2/3 Active not recruiting

Thyroid Neoplasms, Thyroid Nodule

NCT05710406 2026-01-26

Testing the Use of BRAF-Targeted Therapy After Surgery and Usual Chemotherapy for BRAF-Mutated Colon Cancer

1 enrolled

Phase EARLY_PHASE1 Recruiting

Colonic Neoplasms

NCT07025226 2026-01-26

Senolytics

10 enrolled

CNS

Glioma

NCT02914873 2026-01-20

PCASTT

2,008 enrolled

Prostatic Neoplasms

NCT06411938 2026-01-16

Merck-3

2,300 enrolled

Phase NA Not yet recruiting

Uterine Cervical Neoplasms

NCT07240220 2026-01-15

Merck-4

2,500 enrolled

Uterine Cervical Dysplasia, Papillomavirus Infections

NCT02882282 2025-10-23

Pembrolizumab in Treating Patients With High Risk Oral Intraepithelial Neoplasia

Phase 2 Completed

15 enrolled 8 charts

Mouth Neoplasms

NCT06200103 2025-09-11

Schedule De-Escalation of 177Lu-PSMA-617 for the Treatment of Metastatic Castrate Resistant Prostate Cancer

236 enrolled

Prostatic Neoplasms

NCT06537154 2025-07-30

NEO-BLAST

Phase 2/3 Recruiting

688 enrolled

Phase 2 Not yet recruiting

Urinary Bladder Neoplasms

NCT06861894 2025-05-15

Active Surveillance After Neoadjuvant Adebrelimab Combined With Chemoradiotherapy for Resectable ESCC

164 enrolled

Phase 2/3 Active not recruiting

Esophageal Squamous Cell Carcinoma

NCT04068103 2025-05-07

Circulating Tumor DNA Testing in Predicting Treatment for Patients With Stage IIA Colon Cancer After Surgery

635 enrolled 9 charts

Phase 2 Not yet recruiting

Colonic Neoplasms

NCT06686381 2025-02-05

Tetra-modality Bladder Preservation Strategies in Muscle-invasive Bladder Cancer: TURBT+ Chemo/Immunotherapy+ Radiation Therapy+ Maintenance Immunotherapy vs. W&W

80 enrolled

Muscle-invasive Bladder Cancer

NCT01725165 2024-10-24

Surgery and/or Radiation Therapy or Standard Therapy and/or Clinical Observation in Treating Patients With Previously Treated Stage IV Non-small Cell Lung Cancer

Phase 2 Completed

85 enrolled 9 charts

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT06238648 2024-09-26

Epcoritamab Compared to Observation for Treating B-cell Lymphoma Patients Not in Complete Remission After CD19-directed CAR-T Therapy

Lymphoid

Lymphoma, Large B-Cell, Diffuse

NCT05953181 2024-09-19

SANO

776 enrolled

Phase 2 Active not recruiting

Esophageal Neoplasms

NCT00080756 2024-08-28

Deslorelin Combined With Low-Dose Add-Back Estradiol and Testosterone in Preventing Breast Cancer in Premenopausal Women Who Are at High Risk for This Disease

11 enrolled

Breast

Breast Neoplasms

NCT06089369 2024-04-30

Postoperative Adjuvant Sintilimab in Hepatocellular Carcinoma With Microvascular Invasion

Phase 3 Not yet recruiting

360 enrolled

Carcinoma, Hepatocellular

NCT04029714 2024-02-23

Prostate Cancer Active Surveillance Trigger Trial (PCASTT-UK): Comparing Current Practice for Men With Prostate Cancer on Active Surveillance (AS) to an AS Protocol With Standardised Triggers for Transitioning to Curative Treatment

195 enrolled

Prostatic Neoplasms

NCT04489212 2024-02-08

Study of Mucosal Sparing Adjuvant Radiotherapy After Surgical Exploration in HPV+ Head and Neck Cancer of Unknown Primaries

Phase NA Completed

2 enrolled

Phase EARLY_PHASE1 Terminated

Oropharyngeal Neoplasms

NCT03972943 2024-01-08

CPAP in Treating Obstructive Sleep Apnea in Patients With Polycythemia Vera or Essential Thrombocythemia

8 enrolled

Myeloid

Polycythemia Vera, Thrombocythemia, Essential, Sleep Apnea, Obstructive

NCT01088750 2023-12-13

EuroNetLP1

Phase 4 Completed

225 enrolled

Lymphoid

Hodgkin Disease, Lymphoma

NCT00887432 2021-10-26

Cholecalciferol Supplement in Treating Patients With Localized Prostate Cancer Undergoing Observation

Phase NA Completed

132 enrolled 11 charts

Other solid neoplasmThoracic

Prostate Adenocarcinoma

NCT01085630 2021-08-18

Pemetrexed Disodium/Observation in Treating Patients W/ Malignant Pleural Mesothelioma w/Out Progressive Disease After 1st Line Chemotherapy

Phase 2 Completed

72 enrolled 12 charts

Mesothelioma, Malignant, Solitary Fibrous Tumor, Pleural

NCT04919460 2021-06-09

Research on Optimization and Evaluation of Oral Cancer Screening Methods

Phase EARLY_PHASE1 Unknown

10,000 enrolled

Mouth Neoplasms

NCT01717677 2021-02-10

PREFERE

Phase NA Terminated

457 enrolled